176 related articles for article (PubMed ID: 18981459)
1. Bevacizumab reverses cerebral radiation necrosis.
Wong ET; Huberman M; Lu XQ; Mahadevan A
J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
[No Abstract] [Full Text] [Related]
2. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of cerebral radiation necrosis by bevacizumab.
Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
[No Abstract] [Full Text] [Related]
4. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.
Benoit A; Ducray F; Cartalat-Carel S; Psimaras D; Ricard D; Honnorat J
J Neurol; 2011 Feb; 258(2):328-9. PubMed ID: 20862487
[No Abstract] [Full Text] [Related]
5. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
6. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of radiation-induced temporal lobe necrosis with mouse nerve growth factor.
Wang X; Ying H; Zhou Z; Hu C; Eisbruch A
J Clin Oncol; 2011 Mar; 29(7):e166-8. PubMed ID: 21149661
[No Abstract] [Full Text] [Related]
8. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
[TBL] [Abstract][Full Text] [Related]
9. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
10. [Bevacizumab for the treatment of cerebral radionecrosis].
Gronier S; Bourg V; Frenay M; Cohen M; Mondot L; Thomas P; Lebrun C
Rev Neurol (Paris); 2011 Apr; 167(4):331-6. PubMed ID: 21420137
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
12. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment.
DeSalvo MN
J Radiol Case Rep; 2012 Jul; 6(7):9-16. PubMed ID: 23365707
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
14. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
17. Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature.
Sanborn MR; Danish SF; Rosenfeld MR; O'Rourke D; Lee JY
Clin Neurol Neurosurg; 2011 Nov; 113(9):798-802. PubMed ID: 21906869
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization.
Arriola-Villalobos P; Donate-López J; Calvo-González C; Reche-Frutos J; Alejandre-Alba N; Díaz-Valle D
Acta Ophthalmol; 2008 Feb; 86(1):115-6. PubMed ID: 17680838
[No Abstract] [Full Text] [Related]
19. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
Ma Y; Zheng C; Feng Y; Xu Q
J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.
Boström JP; Seifert M; Greschus S; Schäfer N; Glas M; Lammering G; Herrlinger U
Strahlenther Onkol; 2014 Apr; 190(4):416-21. PubMed ID: 24429478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
